These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1830065)

  • 1. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor.
    Fanslow WC; Clifford KN; Park LS; Rubin AS; Voice RF; Beckmann MP; Widmer MB
    J Immunol; 1991 Jul; 147(2):535-40. PubMed ID: 1830065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo.
    Sato TA; Widmer MB; Finkelman FD; Madani H; Jacobs CA; Grabstein KH; Maliszewski CR
    J Immunol; 1993 Apr; 150(7):2717-23. PubMed ID: 8454851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro.
    Maliszewski CR; Sato TA; Vanden Bos T; Waugh S; Dower SK; Slack J; Beckmann MP; Grabstein KH
    J Immunol; 1990 Apr; 144(8):3028-33. PubMed ID: 2139075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4.
    Chilton PM; Fernandez-Botran R
    J Immunol; 1993 Dec; 151(11):5907-17. PubMed ID: 8245438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor.
    Blum H; Wolf M; Enssle K; Röllinghoff M; Gessner A
    J Immunol; 1996 Sep; 157(5):1846-53. PubMed ID: 8757301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The production of soluble interleukin 4 receptors is preferentially regulated by the murine Th2 cell subset.
    Fernandez-Botran R; Chilton PM; Ma Y; Windsor JL; Street NE
    Cytokine; 1997 Mar; 9(3):166-77. PubMed ID: 9126705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor.
    Maliszewski CR; Morrissey PJ; Fanslow WC; Sato TA; Willis C; Davison B
    Cell Immunol; 1992 Sep; 143(2):434-48. PubMed ID: 1511483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
    Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
    J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linked in vivo expression of soluble interleukin-4 receptor and interleukin-4 in murine schistosomiasis.
    Fernandez-Botran R; Wynn TA; Hieny S; Caspar P; Chilton PM; Sher A
    Eur J Immunol; 1995 Mar; 25(3):649-56. PubMed ID: 7705393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble cytokine receptors as carrier proteins: effects of soluble interleukin-4 receptors on the pharmacokinetics of murine interleukin-4.
    Ma Y; Hurst HE; Fernandez-Botran R
    J Pharmacol Exp Ther; 1996 Oct; 279(1):340-50. PubMed ID: 8859012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the expression of the soluble and membrane forms of the murine IL-4 receptor.
    Chilton PM; Fernandez-Botran R
    Cell Immunol; 1997 Sep; 180(2):104-15. PubMed ID: 9341740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseases.
    Nasert S; Millner M; Herz U; Lack G; Wahn U; Gelfand EW; Renz H
    Behring Inst Mitt; 1995 Jun; (96):118-30. PubMed ID: 7575347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).
    König B; Fischer A; König W
    Immunology; 1995 Aug; 85(4):604-10. PubMed ID: 7558156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer of low numbers of CD4+ T cells into SCID mice chronically treated with soluble IL-4 receptor does not prevent engraftment of IL-4-producing T cells.
    Rudolphi A; Enssle KH; Claesson MH; Reimann J
    Scand J Immunol; 1993 Jul; 38(1):57-64. PubMed ID: 8327860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors.
    Antonysamy MA; Fanslow WC; Fu F; Li W; Qian S; Troutt AB; Thomson AW
    J Immunol; 1999 Jan; 162(1):577-84. PubMed ID: 9886435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes.
    Finkelman FD; Madden KB; Morris SC; Holmes JM; Boiani N; Katona IM; Maliszewski CR
    J Immunol; 1993 Aug; 151(3):1235-44. PubMed ID: 8393043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice.
    Kobayashi H; Kobayashi M; Utsunomiya T; Herndon DN; Pollard RB; Suzuki F
    J Immunol; 1999 Jun; 162(12):7148-54. PubMed ID: 10358160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo biological effects of recombinant soluble interleukin-4 receptor.
    Maliszewski CR; Sato TA; Davison B; Jacobs CA; Finkelman FD; Fanslow WC
    Proc Soc Exp Biol Med; 1994 Jul; 206(3):233-7. PubMed ID: 8016157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of B cell activities by interleukin 4 is inhibited by a receptor-specific monoclonal antibody in vitro.
    Maliszewski CR; Sato TA; Vanden Bos T; Beckmann MP; Grabstein KH
    Eur J Immunol; 1990 Aug; 20(8):1735-40. PubMed ID: 2145164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.